HIF-1α modulation is a potential therapeutic target for chronic inflammatory disorders, including sepsis, as it plays a crucial role in hypoxia-induced inducible nitric oxide synthase expression [26,27]. The gene discussed is HIF1A; the disease is Sepsis.